ReShape Lifesciences Inc. (NASDAQ: RSLS)
$4.6600
-0.0600 ( +3.10% ) 4.5K
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Market Data
Open
$4.6600
Previous close
$4.7200
Volume
4.5K
Market cap
$3.23M
Day range
$4.5100 - $4.7390
52 week range
$4.0900 - $29.0000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Dec 27, 2024 |
| 8-k | 8K-related | 29 | Dec 11, 2024 |
| 8-k | 8K-related | 13 | Dec 02, 2024 |
| 10-q | Quarterly Reports | 63 | Nov 14, 2024 |
| 8-k | 8K-related | 16 | Nov 14, 2024 |
| 8-k | 8K-related | 20 | Oct 17, 2024 |
| 8-k | 8K-related | 17 | Sep 24, 2024 |
| 8-k | 8K-related | 16 | Aug 14, 2024 |
| 10-q | Quarterly Reports | 62 | Aug 14, 2024 |
| 4 | Insider transactions | 1 | Aug 13, 2024 |